NCT00490347
Completed
Phase 2
Evaluation of the VentrAssistTM Left Ventricular Assist Device as a Bridge to Cardiac Transplantation - Feasibility Trial
Ventracor5 sites in 1 country30 target enrollmentJuly 2005
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- End-Stage Heart Failure
- Sponsor
- Ventracor
- Enrollment
- 30
- Locations
- 5
- Primary Endpoint
- Survival
- Status
- Completed
- Last Updated
- 18 years ago
Overview
Brief Summary
The purpose of this trial is to determine the safety and feasibility of the VentrAssist LVAD in providing circulatory support for patients who require an LVAD as a bridge to cardiac transplantation.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Survival
Secondary Outcomes
- Neurocognitive function
- Quality of life
- Functional status
Study Sites (5)
Loading locations...
Similar Trials
Unknown
Phase 3
VentrAssistTM LVAD as a Bridge to Cardiac Transplantation - Pivotal TrialEnd-stage Heart FailureCardiomyopathiesNCT00483197Ventracor140
Unknown
Phase 3
VentrAssistTM LVAD for the Treatment of Advanced Heart Failure - Destination TherapyEnd-stage Heart FailureCardiomyopathiesNCT00490321Ventracor225
Completed
Phase 4
Efficacy Study of LV Assist Device to Treat Patients With Cardiogenic Shock (ISAR-SHOCK)Shock, CardiogenicMyocardial InfarctionNCT00417378Deutsches Herzzentrum Muenchen26
Withdrawn
Phase 1
Subcu Administration of CD-NP in Heart Failure Patients With Left Ventricular Assist Device SupportHeart FailureLeft Ventricular Assist DeviceNatriuretic PeptideNCT03091998Mayo Clinic
Not Yet Recruiting
N/A
Clinical research of the left ventricular assist device with post-auricular connectorsevere heart failureJPRN-UMIN000025211Osaka University hospital6